ClinicalTrials.Veeva

Menu

Clinical Trial of H2-BP Electronic Sphygmomanometer

Y

Yonsei University Health System (YUHS)

Status

Completed

Conditions

Hypertension
Normal Blood Pressure
Prehypertension
Low Blood Pressure

Treatments

Device: H2-BP

Study type

Interventional

Funder types

Other

Identifiers

NCT06491433
3-2022-0427

Details and patient eligibility

About

The study compares H2-BP, a wristband blood pressure monitor, with an auscultatory sphygmomanometer. Both devices are used on the same arm. After confirming wrist and upper arm circumference, H2-BP is operated by one measurer, while the auscultatory sphygmomanometer is simultaneously operated by two other measurers. Each subject undergoes alternating measurements of H2-BP on one wrist and the auscultatory sphygmomanometer on the same arm until three valid measurement pairs are obtained per subject, with a maximum of eight repetitions allowed. The two auscultatory sphygmomanometer measurers operate independently and cannot see each other's measurements during the test. Measurements are repeated for 10 to 30 minutes until three valid blood pressure values are obtained and recorded. Validity assessment variables are derived from the recorded values to evaluate the accuracy of H2-BP.

Enrollment

141 patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Outpatients and inpatients aged 19 years or older showing hypotension, normal blood pressure, prehypertension, and hypertension
  • Individuals who meet the criteria for wrist circumference, age, gender, and upper arm circumference as specified in the target number of participants.
  • Those who have listened to a detailed explanation of the clinical trial, fully understand it, voluntarily decide to participate, and provide written consent to comply with precautions.

Exclusion criteria

  • Patients who do not consent to participate in the study.
  • Individuals who may not maintain stable blood pressure for approximately 30 minutes due to conditions resembling hypovolemia or similar conditions.
  • Those who may not maintain stable blood pressure for approximately 30 minutes due to short-acting vasodilators or similar medications.
  • Individuals with arrhythmia.
  • Those who have eaten within 30 minutes before blood pressure measurement.
  • Individuals who have consumed caffeine-containing beverages within 1 hour or smoked within 15 minutes before measurement.
  • Participants who have exercised immediately before blood pressure measurement.
  • Other patients deemed unsuitable for the study at the discretion of the researchers.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

141 participants in 1 patient group

Test subjects using H2-BP and big ben® Sphygmomanometer
Experimental group
Description:
Blood Pressure Measurement with the H2-BP Electronic Sphygmomanometer (H2-BP) and with aneroid Sphygmomanometer(big ben® Sphygmomanometer).
Treatment:
Device: H2-BP

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Byoung Kwon Lee, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems